CASI Pharma (CASI) Reports Q3 Loss of $0.05

CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.05), versus ($0.07) reported last year.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Amrize Ltd (AMRZ) PT Lowered to $42 at UBS on Lower Earnings Estimates
• Premarket movers: Quest, Labcorp hit by CMS cuts